• About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q4 2020

  • March 19, 2021
  • Industry Updates
  • Healthcare, Medical Technology
2020: The Year Medical Technology Development Became Nightly News
  • For a brief moment at its onset, 2020 seemed on its way to being a fairly typical year, with the U.S. stock market performing well and a Presidential Election on the horizon. Quickly though it became clear that society would face unprecedented challenges due to the global outbreak of COVID-19, and that the Medical industry would be called on to try and keep the world healthy. From cutting edge biotechnology companies racing to develop a coronavirus vaccine, to manufacturers of respiratory and personal protective equipment juggling severed international supply chains, nearly all companies in the industry faced disruptions and had a role to play in returning the world to normalcy.
  • During a turbulent year for public equities, PMCF”s four Medical Technology indices generally followed the performance trends of the benchmark S&P 500 Growth Index and Dow Jones Industrial Average, with a similar sharp dip in late Q1 followed by a strong recovery.
  • Though it is still early in 2021 at the time of publication, encouraging signs of recovery from the pandemic are emerging, with over 13% of the U.S. having received at least one vaccine dose, and drugmakers pledging massive boosts to supplies.

 

Read Medical Technology M&A Pulse Q4 2020 Full Report

Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Packaging M&A Update – May 2022
Plastics M&A Update – May 2022
Industrial Distributor M&A Pulse – Q1 2022
Software & Technology M&A Pulse – Q1 2022
Plastics M&A Update – April 2022
Contact

Follow Us On

Securities offered through P&M Corporate Finance, LLC. Member of FINRA and SIPC.

Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

M&A Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

©2021 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​